日企

Nimble Eisai rethinks its game to beat rivals for China's market

The ancient Chinese game of Go requires analytical skills and intuition, and the aim is to enclose territories on the board.

Eisai, Japan's fourth-largest pharmaceutical company, has taken a similar strategy in its approach to the Chinese market, says Pelham Smithers, an independent equities analyst.

“Players of the game Go would recognise Eisai's approach,” says Mr Smithers. “It targets an area, then with a handful of well-placed moves envelops it.”

您已阅读9%(452字),剩余91%(4400字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×